# Optimal Timing of Hepatitis B Vaccination After Transplants

> **NCT06888479** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 1500 (estimated)

## Conditions studied

- Transplant-Related Disorder
- Hepatitis B Virus Infection
- Vaccine Reaction

## Interventions

- **BIOLOGICAL:** hepatitis B vaccine

## Key facts

- **NCT ID:** NCT06888479
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2028-06-01
- **Final completion:** 2029-03-01
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06888479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06888479, "Optimal Timing of Hepatitis B Vaccination After Transplants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06888479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*